Domestic

Community Health Applied Research Network (CHARN)

  • Principal Investigator(s): Kenneth Mayer, MD
  • Study Contact: Kenneth Mayer, MD
  • Description of Subjects: Patients receiving primary care at participating community health centers across the U.S.
  • Location (Domestic vs. International): Boston, MA; greater MA; New England
  • Enrollment Period: 2007-2014
  • Enrollment Goal: >50,000

Optimizing PrEP through Shared Decision Making

  • Principal Investigator(s): Douglas Krakower
  • Study Contact: Douglas Krakower
  • Description of Subjects: HIV-uninfected men who have sex with men
  • Location (Domestic vs. International): BIDMC, Fenway Health, Greater Boston region (i.e., from community)
  • Enrollment Period: 2013 to present
  • Enrollment Goal: 100 participants

The MATCH Study of HIV and Aging

  • Principal Investigator(s): Monty Montano
  • Study Contact: Brooke Ferguson Brawley; BBRAWLEY@PARTNERS.ORG617-525-9195
  • Description of Subjects: Adult males and females, 50-65 years old. If HIV+, on effective ART.
  • Location (Domestic vs. International): Boston Metropolitan Area
  • Enrollment Period: 2015-2016
  • Enrollment Goal: 200

HIV Research Network (HIVRN)

  • Principal Investigator(s): Stephen Boswell, MD
  • Study Contact: Sarah Wolfrum, DrPH, 617-927-6367, swolfrum@fenwayhealth.org
  • Description of Subjects: HIV-infected patients aged 18 and older receiving medical care at Fenway Health. (HIVRN includes pediatric data, but Fenway Health only submits adult patient data)
    • HIV+
    • HIV/HCV Co-infected

CFAR Network of Integrated Clinical Systems (C-NICS)

  • Principal Investigator(s): Stephen Boswell, MD
  • Study Contact: Chris Grasso, Tel: 617-927-6018, cgrasso@fenwayhealth.org
  • Description of Subjects: HIV infected patients receiving primary care at Fenway Health. HIV+, HIV Co-infected
  • Location (Domestic vs. International): Fenway Health: Boston, MA
  • Enrollment Period: 1997 to present (ongoing)

Effect on CNS with ART switch off EFV-based therapy

  • Principal Investigator(s): Nina LIn
  • Study Contact:  Nina Lin, Tel: 617-768-8479, nhlin@partners.org
  • Description of Subjects:  Effect on CNS with ART switch off EFV-based therapy
  • Location (Domestic vs. International): Domestic, BWH (recruiting can be from MGH or BIDMC)
  • Enrollment Period: Beginning January 2014

HIV and Aging Cohort Study

  • Principal Investigator(s): Nina Lin
  • Study Contact:  Nina Lin, Tel: 617-768-8479, nhlin@partners.org
  • Description of Subjects:  HIV+ on ART who are </= 35 yo or >/=50yo with no hepatitis co-infection
  • Location (Domestic vs. International): Domestic, BWH, BIDMC, MGH
  • Enrollment Period: 2011-present
  • Enrollment Goal: 

Pediatric HIV/AIDS Cohort Study (PHACS -BCH site only)

  • Principal Investigator(s): Sandra Burchett (site leader), George Seage PI
  • Study Contact: Sandra Burchett, MD, Tel. 617 355-6832, sandra.burchett@childrens.harvard.edu
  • Description of Subjects: AMP:450 HIV+ youth, 150 HIV-controls; SMARRT: >1700 HIV neg/ARV exposed infants,youth. Study domains: cardiopulm, metabol, complications and HIV disease, maternal exposures, neuro, oral health, adolescent

Pages